Research - Basel, Basel-Stadt, Switzerland
Affivant is dedicated to developing novel immune-oncology approaches to activate and enable the innate immune system to fight cancer. Our innovative bi-specific innate cell engagers are designed to target specific patient populations as powerful monotherapies and combination treatments.
Outlook
Dyn Managed DNS
Mobile Friendly
Google Cloud Hosting